These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2588923

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Correctable complications of neoplastic disease. 3. Neoplastic effusions.
    Farber LR.
    Conn Med; 1971 Jun; 35(6):411-2. PubMed ID: 5165442
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
    Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):791-9. PubMed ID: 16467090
    [Abstract] [Full Text] [Related]

  • 25. [The role of pleural effusion cytology in the diagnosis of malignancies].
    Mermolja M, Debeljak A.
    Plucne Bolesti; 1989 Feb 01; 41(3-4):146-9. PubMed ID: 2636394
    [Abstract] [Full Text] [Related]

  • 26. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
    Dequanter D, Lothaire P, Berghmans T, Sculier JP.
    Ann Surg Oncol; 2008 Nov 01; 15(11):3268-71. PubMed ID: 18648881
    [Abstract] [Full Text] [Related]

  • 27. [Presumption of primary sites from cytological findings--with reference to adenocarcinoma cells in the effusions in body cavities].
    Takamura Y, Tajima M.
    Rinsho Byori; 1990 Nov 01; Suppl 87():126-40. PubMed ID: 2287083
    [No Abstract] [Full Text] [Related]

  • 28. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K.
    Clin Cancer Res; 1997 Jan 01; 3(1):47-50. PubMed ID: 9815536
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 31. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
    Aoe K, Hiraki A, Yamazaki K, Nakamura Y, Murakami T, Maeda T, Nishimura M, Sugi K, Ueoka H.
    Int J Oncol; 2006 Jul 01; 29(1):65-72. PubMed ID: 16773186
    [Abstract] [Full Text] [Related]

  • 32. Electron microscopic studies of cells in pleural and peritoneal effusions.
    Murad TM.
    Acta Cytol; 1973 Jul 01; 17(5):401-9. PubMed ID: 4517952
    [No Abstract] [Full Text] [Related]

  • 33. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 34. Malignant effusions: from diagnosis to biology.
    Davidson B.
    Diagn Cytopathol; 2004 Oct 15; 31(4):246-54. PubMed ID: 15452897
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cytologic diagnosis and chromosome analysis: sensitivity, specificity, accuracy and predictive value in malignant and benign pleural effusions.
    Giazza G, Cosimi MF, Lanero M, Rossi GP, Casagranda I.
    Pathologica; 1990 Oct 15; 82(1077):33-40. PubMed ID: 2362783
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Oct 15; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 39. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A, Lynne LC, Howell L.
    Diagn Cytopathol; 2007 Feb 15; 35(2):105-10. PubMed ID: 17230576
    [Abstract] [Full Text] [Related]

  • 40. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD.
    Cancer Res; 1988 Sep 01; 48(17):5023-8. PubMed ID: 3165707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.